CONTOUR BGM Portfolio Development
Diabetes Management
CommercialActive
Key Facts
About Ascensia Diabetes Care
Ascensia Diabetes Care is a global, pure-play diabetes company focused on diagnostics and digital health solutions. It operates as a subsidiary of PHC Holdings, having been formed through the acquisition of Bayer Diabetes Care in 2016. The company's core business revolves around its CONTOUR brand of blood glucose monitoring systems and complementary digital tools for diabetes management. With a strong commercial footprint and a patient-centric approach, Ascensia aims to innovate within the diabetes care continuum while integrating ESG principles into its corporate strategy.
View full company profileTherapeutic Areas
Other Diabetes Management Drugs
| Drug | Company | Phase |
|---|---|---|
| CGM Integrations (Dexcom, Abbott) | Tandem Diabetes | Partnership |
| ALRT Diabetes Solution | ALR Technologies | Approved/Commercial |
| Continuous Glucose Monitor | Allez Health | Approved |
| Next-Gen Sensor & Algorithm Development | Medtrum France | Development |
| Regulatory Expansion (e.g., FDA Submission) | Medtrum France | Regulatory |
| Next-Gen Hardware/Software | Insulet | R&D |
| CGM Ecosystem Integration | Insulet | Development/Regulatory |